Through further bioinformatics analysis and luciferase assays, miR-4443 was shown to regulate FSP1 expression in an N6-methyladenosine-dependent manner through its target gene methyltransferase-like 3 (METTL3) and increase the resistance of tumour cells to ferroptosis, promoting resistance to cisplatin in NSCLC [84]. The gene discussed is METTL3; the disease is non-small cell lung carcinoma.